Vitamin B6 dependent seizures

Canadian Journal of Neurological Sciences

Volumn 36, Issue SUPPL. 2, 2009, Pages

  Plecko, Barbara ^a,b   Stöckler, Sylvia ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXINE;

CHEMICAL ANALYSIS; CONFERENCE PAPER; DIAGNOSTIC TEST; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME METABOLISM; EPILEPSY; GENETIC ANALYSIS; HEREDITY; HUMAN; HYPERPROLINEMIA; HYPOPHOSPHATASIA; INBORN ERROR OF METABOLISM; INFANTILE HYPOPHOSPHATASIA; MYOCLONUS SEIZURE; NERVOUS SYSTEM INJURY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; PYRIDOXAL PHOSPHATE DEPENDENT EPILEPSY; PYRIDOXINE DEFICIENCY; PYRIDOXINE DEPEDENT SEIZURE; PYRIDOXINE DEPENDENT SEIZURE; SEIZURE; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION; ANIMAL; ELECTROENCEPHALOGRAPHY; GENETICS; METABOLISM; REVIEW;

ANIMALS; ELECTROENCEPHALOGRAPHY; HUMANS; PYRIDOXAL PHOSPHATE; PYRIDOXAMINEPHOSPHATE OXIDASE; SEIZURES; VITAMIN B 6;

EID: 69249139018     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Kuo MF, Wang HS. Pyridoxal-phosphate responsive epilepsy with resistance to pyridoxine. Pediatr Neurol. 2002;26:146-7.
2. Clayton PT, Surtees RA, DeVile C, Hyland K, Heales SJ. Neonatal epileptic encephalopathy. Lancet. 2003;361:1614.
3. Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum Mol Genet. 2005 Apr 15;14(8): 1077-86.
4. Hoffmann GF, Schmitt B, Windfuhr M, Wagner N, Strehl H, Bagci S, et al. Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis. 2007 Feb;30(1): 96-9.
5. Litmanovitz, Reish O, Dolfin T, Arnon S, Regev R, Grinshpan G, et al. Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis. 2002;25(1): 35-40.
6. Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Bürgi S, Sergi C, Ryan L, et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone. 2007; 40(6):1655-61.
7. Hunt AD, Stokes J, McCrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954;13(2):140-5.
8. Battaglioli G, Rosen DR, Gospe SM Jr, Martin DL. Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures. Neurology. 2000;55:309-11.
9. Cormier-Daire V, Dagoneau N, Nabbout R, Burglen L, Penet C, Soufflet C, et al. A gene for pyridoxine-dependent epilepsy maps to Chromosome 5q31. A. J Hum Genet. 2000;67:991-3.
10. Plecko B, Stöckler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol. 2000 Jul;48(1):121-5.
11. Plecko B, Hikel C, Korenke GC, Schmitt B, Baumgartner M, Baumeister F, et al. Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics. 2005 Jun;36 (3):200-5.
12. Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, et al. Mutations in antiquitin in individuals with pyridoxinedependent seizures. Nature Medicine. 2006; 307-9.
13. Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, et al. Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat. 2007, 28(1):19-26.
14. Salomons GS, Bok LA, Struys EA, Pope LL, Darmin PS, Mills PB, et al. An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1). Ann Neurol. 2007 Oct;62(4):414-8.
15. Kanno J, Kure S, Narisawa A, Kamada F, Takayanagi M, Yamamoto K, et al. Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. Mol Genet Metab. 2007. 91(4):384-9.
16. Gospe SM Jr. Current perspectives on pyridoxine-dependent seizures. J Pediatr. 1998 Jun;132(6):919-23.
17. Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta. 2003 Apr 11;1647(1-2): 36-41.
18. Rankin PM, Harrison S, Chong WK, Boyd S, Aylett SE. Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev Med Child Neurol. 2007; 49(4):300-5.
19. Farrant RD,Walker V, Mills GA, Mellor JM, Langley GJ. Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem. 2001;276(18):15107-16.
20. Flynn MP, Martin MC, Moore PT, Stafford JA, Fleming GA, Phang JM. Type II hyperprolinemia in a pedigree of Irish travelers. Arch Dis Child. 1989;64:1699.